Lista de obras - Antonio D'Avolio - Dominio Público Uruguay

25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2

scientific article published on 09 May 2020

A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.

artículo científico publicado en 2010

A LC-MS method to quantify tenofovir urinary concentrations in treated patients.

artículo científico publicado en 2015

A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir

artículo científico publicado en 2013

A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease

artículo científico publicado en 2008

A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting.

artículo científico publicado en 2008

A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method

artículo científico publicado en 2006

A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma.

artículo científico publicado en 2014

A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients.

artículo científico publicado en 2010

An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients

artículo científico publicado en 2008

An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients

artículo científico publicado en 2006

Anidulafungin for Candida glabrata infective endocarditis

artículo científico publicado en 2012

Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir

artículo científico publicado en 2008

Calcyclin gene expression modulation by medroxyprogesterone acetate ⬇️

artículo científico publicado el 15 de julio de 1997

Cannabinoids concentration variability in cannabis olive oil galenic preparations

artículo científico publicado en 2017

Ceftriaxone bone penetration in patients with septic non-union of the tibia

scientific article published on 15 April 2011

Cerebrospinal Fluid Abacavir Concentrations in HIV-positive Patients Following Once-daily Administration.

artículo científico publicado en 2018

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma

artículo científico publicado en 2017

Comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid".

artículo científico publicado en 2013

Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens

artículo científico publicado en 2010

Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn's Disease

artículo científico publicado en 2024

Detection of stavudine concentrations in plasma of HIV-infected patients taking zidovudine

artículo científico publicado en 2004

Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics

artículo científico publicado en 2012

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

artículo científico publicado en 2013

Development and validation of UHPLC-MS/MS methods for the quantification of colistin in plasma and dried plasma spots

artículo científico publicado en 2016

Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots.

artículo científico publicado en 2013

Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS

scientific article published on 07 August 2012

Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma

artículo científico publicado en 2009

Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients

artículo científico publicado en 2012

Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients.

artículo científico publicado en 2013

Development and validation of an HPLC-UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV-positive patients

artículo científico publicado en 2018

Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.

artículo científico publicado en 2010

Differential dose adjustments of immunosuppressants after resuming boosted versus unboosted HIV-protease inhibitors postliver transplant

artículo científico publicado en 2009

Drug interactions between warfarin and efavirenz or lopinavir-ritonavir in clinical treatment

artículo científico publicado en 2008

Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients

artículo científico publicado en 2020

Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient.

artículo científico publicado en 2017

Enhancement of calcyclin gene RNA expression in squamous cell carcinoma of the oral mucosa, but not in benign lesions

scientific article published on 01 May 1997

Estimating ribavirin plasma exposure: genetics or therapeutic drug monitoring?

artículo científico publicado en 2013

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection

artículo científico publicado en 2017

Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations.

artículo científico publicado en 2011

Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy

artículo científico publicado en 2022

Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.

artículo científico publicado en 2008

HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions

artículo científico publicado en 2010

HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)

artículo científico publicado en 2011

HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.

artículo científico publicado en 2007

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.

artículo científico publicado en 2010

In vitro activity of propolis against Streptococcus pyogenes

artículo científico publicado en 2000

Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.

artículo científico publicado en 2012

Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab

scientific article published on 21 January 2019

Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane

artículo científico publicado en 2013

Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells

artículo científico publicado en 2012

Is peritoneal fluid a sanctuary site for HIV?

artículo científico publicado en 2010

Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.

artículo científico publicado en 2013

L-histidine/medroxyprogesterone acetate interaction modulates human breast cancer cell growth and progestin receptor expression in vitro.

artículo científico publicado en 1997

LC-MS application for therapeutic drug monitoring in alternative matrices

artículo científico publicado en 2018

Lack of interaction between raltegravir and cyclosporin in an HIV-infected liver transplant recipient.

artículo científico publicado en 2009

Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders

artículo científico publicado en 2020

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism

artículo científico publicado en 2010

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis ⬇️

artículo científico publicado en 2011

Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment.

artículo científico publicado en 2012

New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.

artículo científico publicado en 2009

Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir.

artículo científico publicado en 2018

Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients

artículo científico publicado en 2008

Pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers.

artículo científico publicado en 2011

Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients.

artículo científico publicado en 2005

Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers.

artículo científico publicado en 2011

Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors

artículo científico publicado en 2012

Pharmacokinetics of linezolid during extracorporeal membrane oxygenation

artículo científico publicado en 2013

Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients

artículo científico publicado en 2013

Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients

article

Pharmacokinetics of the raltegravir/maraviroc/etravirine combination

scientific article published on 04 June 2011

Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance

artículo científico publicado en 2010

Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis

scientific article published on 20 October 2010

Raltegravir penetration in seminal plasma of healthy volunteers

artículo científico publicado en 2010

Raltegravir penetration in the cerebrospinal fluid of HIV-positive patients

artículo científico publicado en 2010

Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4.

artículo científico publicado en 2011

Ritonavir-dependent fluconazole boosting of nelfinavir: a report of three cases

artículo científico publicado en 2006

Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes

artículo científico publicado en 2013

Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study

artículo científico publicado en 2011

Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir

artículo científico publicado en 2013

Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV.

artículo científico publicado en 2009

Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults

artículo científico publicado en 2008

Telbivudine in the treatment of hepatitis B-associated cryoglobulinemia

artículo científico publicado en 2012

Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage

artículo científico publicado en 2011

Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting

artículo científico publicado en 2009

The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon

artículo científico publicado en 2008

Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study

artículo científico publicado en 2024

Therapeutic drug monitoring of intracellular anti-infective agents.

artículo científico

Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence

artículo científico publicado en 2018

Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimens.

artículo científico publicado en 2007

Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy

artículo científico publicado en 2013

Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.

artículo científico publicado en 2010

Unexpected drug–drug interaction between tipranavir/ritonavir and enfuvirtide

artículo científico publicado en 2006

Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV

artículo científico publicado en 2020

Validation of liquid/liquid extraction method coupled with HPLC-UV for measurement of ribavirin plasma levels in HCV-positive patients

artículo científico publicado en 2006

Lista de obras de Antonio D'Avolio

25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2

A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.

A LC-MS method to quantify tenofovir urinary concentrations in treated patients.

A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir

A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease

A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting.

A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method

A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma.

A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients.

An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients

An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients

Anidulafungin for Candida glabrata infective endocarditis

Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir

Calcyclin gene expression modulation by medroxyprogesterone acetate ⬇️

Cannabinoids concentration variability in cannabis olive oil galenic preparations

Ceftriaxone bone penetration in patients with septic non-union of the tibia

Cerebrospinal Fluid Abacavir Concentrations in HIV-positive Patients Following Once-daily Administration.

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma

Comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid".

Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens

Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn's Disease

Detection of stavudine concentrations in plasma of HIV-infected patients taking zidovudine

Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

Development and validation of UHPLC-MS/MS methods for the quantification of colistin in plasma and dried plasma spots

Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots.

Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS

Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma

Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients

Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients.

Development and validation of an HPLC-UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV-positive patients

Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.

Differential dose adjustments of immunosuppressants after resuming boosted versus unboosted HIV-protease inhibitors postliver transplant

Drug interactions between warfarin and efavirenz or lopinavir-ritonavir in clinical treatment

Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients

Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient.

Enhancement of calcyclin gene RNA expression in squamous cell carcinoma of the oral mucosa, but not in benign lesions

Estimating ribavirin plasma exposure: genetics or therapeutic drug monitoring?

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection

Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations.

Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy

Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.

HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions

HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)

HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.

In vitro activity of propolis against Streptococcus pyogenes

Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.

Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab

Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane

Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells

Is peritoneal fluid a sanctuary site for HIV?

Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.

L-histidine/medroxyprogesterone acetate interaction modulates human breast cancer cell growth and progestin receptor expression in vitro.

LC-MS application for therapeutic drug monitoring in alternative matrices

Lack of interaction between raltegravir and cyclosporin in an HIV-infected liver transplant recipient.

Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis ⬇️

Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment.

New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.

Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir.

Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients

Pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers.

Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients.

Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers.

Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors

Pharmacokinetics of linezolid during extracorporeal membrane oxygenation

Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients

Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients

Pharmacokinetics of the raltegravir/maraviroc/etravirine combination

Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance

Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis

Raltegravir penetration in seminal plasma of healthy volunteers

Raltegravir penetration in the cerebrospinal fluid of HIV-positive patients

Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4.

Ritonavir-dependent fluconazole boosting of nelfinavir: a report of three cases

Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes

Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study